Bio Protocol $BIO is a decentralized platform for funding, developing, and owning tokenized biotech projects and IP. More
| Fully Diluted Valuation | $494.22M |
|---|---|
| 24H Trading Volume | $68.32M |
| 24H Low / High | $0.15 / $ 0.16 |
| Circulating Supply | 1.89B |
| Total Supply | 3.32B |
| Max Supply | 3.32B |
| Categories | Decentralized Science (DeSci) 4 more |
|---|---|
| Founder | Paul Kohlhaas 2 more |
| Website | bio.xyz Whitepaper |
| Socials | 2 more |
| Chains | Ethereum Ecosystem 2 more |
| Explorer | Basescan 3 more |
| Contracts |
0xcb1....e5ffa
2 more
|
| Name | Pair | OG Score |
|---|
Bio Protocol $BIO is a pioneering initiative in the Decentralized Science (DeSci) space, designed to accelerate biotechnology innovation. Its mission is to empower global communities of patients, scientists, and biotech professionals to fund, develop, and own tokenized biotech projects and intellectual property (IP). By leveraging onchain scientific economies, Bio Protocol $BIO aims to drive decentralized funding, incentives, and liquidity for early-stage scientific research.
The creators of Bio Protocol $BIO are no strangers to DeSci. The team has previously developed Molecule, a tokenization platform for biomedicine, and VitaDAO, the largest decentralized community dedicated to longevity science. These achievements form the foundation for Bio Protocol $BIO, which aspires to become the financial layer for DeSci by commercializing groundbreaking scientific research.
The $BIO token serves as the gateway to its network, granting access to scientific communities and IP while offering exposure to the DeSci economy.
Key Features of Bio Protocol $BIO
Meta-Governance
Bio Protocol $BIO enables governance across a range of biotech DAOs and IP assets. This meta-governance mechanism ensures broad participation and influence in the DeSci space.
Funding
It channels funding to specific scientific missions or individual IP assets while incentivizing activities within the network.
Liquidity
The platform creates globally accessible liquidity pathways, enabling seamless exchanges across the Bio Protocol $BIO ecosystem.
Launchpad
The Bio Launchpad is a core component, allowing the formation, curation, and funding of BioDAOs. This tool makes decentralized science more accessible and user-friendly.
Use Cases
Funding Scientific Research: Bio Protocol $BIO facilitates funding for early-stage biotech projects, university research, and corporate initiatives.
Tokenized IP Ownership: The platform allows individuals and DAOs to own and govern tokenized IP assets.
Community-Driven Innovation: By forming BioDAOs, communities can collaborate on specific areas of scientific research, such as longevity, synthetic biology, and rare diseases.
Founders and Team
The leadership team of Bio Protocol $BIO includes:
Paul Kohlhaas: Tokenomics expert.
James Sinka: R&D and Community Manager.
Jose Pinto: Legal Counsel.
Leonard Boltz: Product Developer.
Nate Hindman: Growth Specialist.
Stefano Glauser: Operations Leader.
Additionally, the team is supported by advisors like Tyler Golato (Research Dealflow) and Vincent Weisser (AI and Research).
Backers and Partners
Bio Protocol $BIO has garnered significant support from the crypto and biotech sectors. Key milestones include:
Pfizer Ventures backing VitaDAO with a $4.1 million investment.
Binance Labs investing in Bio Protocol $BIO in November 2024.
Partnerships with leading universities and research entities like the University of Copenhagen and Newcastle University.
Ecosystem
Bio Protocol $BIO operates with a growing network of biotech-focused DAOs, including:
VitaDAO: Longevity research.
ValleyDAO: Synthetic biology.
AthenaDAO: Women’s health research.
PsyDAO: Psychedelic science.
HairDAO: Addressing hair loss.
CryoDAO: Cryopreservation research.
These DAOs collectively represent a diverse array of scientific areas and demonstrate the platform's versatility.
Conclusion
Bio Protocol $BIO aims to redefine the funding and development of scientific innovation in the biotech industry. By bridging blockchain technology with decentralized scientific communities, it positions itself as a transformative force in the DeSci ecosystem.
Bio Protocol $BIO enables decentralized funding, tokenized IP ownership, and liquid biotech economies in the DeSci space.
The founders are Paul Kohlhaas, James Sinka, and Jose Pinto.
Bio Protocol $BIO is backed by Pfizer Ventures, Binance Labs, and partnered with universities like the University of Copenhagen.
Join
OGAudit
